allicin has been researched along with homocysteine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mirelman, D; Miron, T; Oron-Herman, M; Rabinkov, A; Rosenthal, T; Sela, BA; Wilchek, M | 1 |
| Gao, W; Guo, RC; Jia, Q; Liang, ES; Lin, WW; Liu, DS; Wang, SL; Zhang, JD; Zhang, WD | 1 |
2 other study(ies) available for allicin and homocysteine
| Article | Year |
|---|---|
The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cyclopropanes; Disease Models, Animal; Disulfides; Homocysteine; Hypertension; Hypoglycemic Agents; Insulin; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Risk Factors; Sulfinic Acids; Treatment Outcome; Triglycerides | 2005 |
Effects of allicin on hyperhomocysteinemia-induced experimental vascular endothelial dysfunction.
Topics: Animals; Aorta; Disulfides; Endothelins; Endothelium, Vascular; Fibroblast Growth Factor 2; Gene Expression Regulation; Homocysteine; Hyperhomocysteinemia; Intercellular Adhesion Molecule-1; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Wistar; Sulfinic Acids; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2013 |